National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program - Fiscal Year 2026 75N91025R00005
Summary
AI-generated · Aug 25, 2025Development of therapeutic or preventative technologies for pediatric cancers and/or rare cancers, and development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis in these populations. Rare cancers with a 5-year survival rate below 50% are encouraged, with rarity defined by the NIH Genetics and Rare Diseases Information Center; use the SEER database for context on survival rates. Preliminary data are not required, but proposals should have a sound scientific premise based on the offeror’s own research or literature, identify an anticipated product and its development path, clearly specify the clinical problem and cancer type(s) with justification, and propose experiments to obtain initial de-risking and proof-of-concept data.
Awards will include requirements to enhance entrepreneurship skills and to develop or refine a business model and commercialization plan, and this Concept Award program may serve as a pipeline into the federal SBIR program.
The National Cancer Institute is soliciting proposals from small business concerns to perform key activities to demonstrate technical feasibility and proof-of-concept for the development of highly innovative and potentially transformative technologies in the following areas: Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers. For this solicitation rare cancers with a 5-year survival rate of less than 50 % are encouraged and rare cancers would be defined as including all the cancers listed by the NIH Genetics and Rare Diseases Information Center. The list can be found here: https://rarediseases.info.nih.gov/search-result?category=Cancer. Access the NCI Surveillance, Epidemiology, and End Results Program (SEER) database (https://seer.cancer.gov/) for more information regarding 5-year cancer survival rates. Preliminary data is not required; however, the ideas should have sound scientific premise either based on the offeror s own research or literature evidence. Proposals will need to identify an anticipated product that will be developed and clearly lay out the anticipated development path. Proposals will need to clearly identify the clinical problem and cancer type(s) that the proposal will focus on with adequate justification. In addition, the offerors should propose experiments to obtain initial de-risking and proof-of-concept data. Awards will also include requirements to enhance entrepreneurship skills and to develop or refine a business model and commercialization plan. This solicitation is a Concept Award program that could serve as a pipeline for the federal Small Business Innovation Research (SBIR) program. Background for the SBIR program can be found in the Small Business Administration s policy directive found here: https://www.sbir.gov/sites/default/files/SBA%20SBIR_STTR_POLICY_DIRECTIVE_May2023.pdf
From Solicitation posted on Jul 08, 2025Notice history
1-
Solicitation LATEST Posted Jul 08, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA